Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-28

Clinical Trial Update: Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for a novel Type 3 oral poliomyelitis vaccine conducted in Panama for poliomyelitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Novel Type 3 Oral Poliomyelitis Vaccine (Oral Poliovirus Vaccine Type 3)

Snippet

Sponsor: PATH | Conditions: Poliomyelitis | Phase 2 | Status: UNKNOWN